AstraZeneca Pharma India Limited on Wednesday announced that it has received permission to import for sale and distribution of Trastuzumab deruxtecan lyophilized powder for concentrate for ...

In a significant development for India's pharmaceutical industry, Enhertu (trastuzumab deruxtecan), an oncology drug marketed by AstraZeneca, recorded the highest sales among newly launched drugs ...

The company reported a robust set of numbers for the December quarter of FY25, with its profit nearly doubling year-on-year ...

Find all the commercial and brand names of generic drug called Trastuzumab. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

Earlier Trastuzumab, another cancer drug, cost ₹70,000-80,000 per month, but the price dropped to ₹12,000 a month when Indian companies started manufacturing it, he said. When more Indian ...

Trastuzumab, tested only as a single agent, has been shown to achieve 7% response in heavily pretreated patients with AOC with 3+ and 2+ HER2 immunostaining by immunohistochemistry (IHC).